Structural Determinants of the Capacity of Heparin to Inhibit the Formation of the Human Amplification C3 Convertase
Open Access
- 1 January 1981
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 67 (1), 223-228
- https://doi.org/10.1172/jci110017
Abstract
The ability of heparin glycosaminoglycan to prevent formation of the properdin-stabilized amplification C3 convertase is independent of antithrombin binding activity and requires substitution of the amino sugar and a degree of oxygen (O)-sulfation which could be on the uronic acid or the amino sugar. Preparations of heparin glycosaminoglycan isolated by different techniques from different species (rat, human, and porcine) exhibited an equivalent capacity to inhibit generation of the amplification C3 convertase. Hyaluronic acid, which is devoid of O-sulfation, had no inhibitory activity; chondroitin 4-sulfate of rat and whale origins, chondroitin 6-sulfate of rat and shark origins, and dermatan sulfate from porcine skin are O-sulfated on the galactosamine and had minimal activity. Porcine heparin glycosaminoglycan, isolated on the basis of affinity for antithrombin III, had no greater anticomplementary activity than porcine glycosaminoglycan, which failed to bind antithrombin III and had essentially no anticoagulant activity. Nitrogen (N)-desulfation of porcine heparin reduced anticomplementary activity to the level of the other sulfated mucopolysaccharides, and both N-resulfation and N-acetylation restored the original activities, thereby indicating a requirement for N-substitution, but not N-sulfation. N-resulfation of N-desulfated and O-desulfated heparin did not restore any activity, thus indicating that O-sulfation and N-substitution represent independent, critical structural requirements for the anticomplementary activity of heparin glycosaminoglycan. Inasmuch as N-desulfated-N-acetylated heparin had no anticoagulant activity, the nature of the N-substitution completely distinguishes the plasma-protein effector pathway that is inhibited.Keywords
This publication has 33 references indexed in Scilit:
- A proteoglycan form of heparin and its degradation to single-chain molecules.Journal of Biological Chemistry, 1978
- Structure-function relationships of heparin speciesProceedings of the National Academy of Sciences of the United States of America, 1978
- Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin.The Journal of Experimental Medicine, 1978
- Solvolytic desulfation of glycosaminoglycuronan sulfates with dimethyl sulfoxide containing water or methanolCarbohydrate Research, 1977
- Immunologic Release of Heparin from Purified Rat Peritoneal Mast CellsThe Journal of Immunology, 1977
- Activation of the alternative complement pathway due to resistance of zymosan-bound.Proceedings of the National Academy of Sciences of the United States of America, 1977
- Native heparin from rat peritoneal mast cells.Journal of Biological Chemistry, 1977
- Mode of interaction of different polyanions with the first (C1, CImmunochemistry, 1976
- Mode of interaction of different polyanions with the first (Immunochemistry, 1976
- Mode of interaction of different polyanions with the first (Immunochemistry, 1976